Elgi Equipments has launched its innovative Demand=Match system for air compressors. This system automatically adjusts compressor delivery to match real-time plant demands, leading to up to 17% energy savings. It aims to provide VFD-like energy savings with the simplicity of fixed-speed machines, reducing energy losses and improving equipment life. The Demand=Match system is now available in India on EG and EQ series compressors.

Demand=Match System Unveiled

Elgi Equipments has announced the launch of its Demand=Match system, designed to optimize the operation of fixed-speed compressors under fluctuating demand. The new system was launched on September 19, 2025, and it represents a significant advancement in energy efficiency for air compression technology.

Key Features and Benefits

The Demand=Match system works by intelligently recirculating airflow within the compressor to ensure that delivery matches real-time demand. Key benefits include:

• Energy Savings: Up to 17% energy reduction in typical operating profiles.
• Improved Reliability: Fewer cut-in and cut-out cycles to reduce mechanical stress and component wear.
• Cost Efficiency: A capital-light implementation that ensures equipment longevity.

Management Commentary

Dr. K. Venu Madhav, Executive President – Product Excellence & Innovation at Elgi Equipments Limited, stated that the system continuously monitors pressure and modulates airflow, ensuring smoother operation and lower energy use. According to him it delivers what is required by the plant, no more and no less.

Availability

The Demand=Match system is currently available in India as a factory-fit option on Elgi’s EG and EQ series compressors. Information on regional availability, pricing, and retrofit compatibility can be obtained from local Elgi representatives. Elgi aims to accelerate adoption across industries, including textiles, automotive, pharmaceuticals, food & beverage, electronics, and general engineering.

Source: BSE

Sterling and Wilson Solar Solutions Inc. (SWSS), a step-down subsidiary of Sterling and Wilson Renewable Energy Ltd., faced a drawdown of a standby letter of credit amounting to USD 7,187,989.98 (approximately INR 63.47 Crores) by a customer. The amount has been reimbursed, and SWSS will pursue recovery from the customer through ongoing litigation.

Standby Letter of Credit Drawdown

A standby Letter of Credit issued in favor of a customer of Sterling and Wilson Solar Solutions Inc. (“SWSS”), a step-down subsidiary, has been drawn down. The drawn amount totals USD 7,187,989.98, equivalent to approximately INR 63.47 Crores. The company disclosed the initial details in their financial results for the quarter ended June 30, 2025.

Details of Reimbursement and Recovery

The amount drawn under the Standby Letter of Credit has already been reimbursed. SWSS is actively pursuing the recovery of this amount from the customer through existing litigation processes.

Details of the Claim

Claimant: Montague Solar LLC

Opposing Party: Sterling and Wilson Solar Solutions Inc. (SWSS)

SWSS will examine and pursue claim recovery from Montague Solar LLC under the ongoing litigation with them.

Source: BSE

Rail Vikas Nigam Limited (RVNL) has emerged as the lowest bidder (L1) from Southern Railway for a project involving the design, supply, erection, testing, and commissioning of traction sub stations. This includes Power Quality Compensating Equipment for 2×25 kV AT Feeding System and SCADA in the Jolarpettai Jn. – Salem Jn. section. The project aligns with Mission 3000MT Loading Target.

Southern Railway Project Win

Rail Vikas Nigam Limited (RVNL) has secured its position as the lowest bidder (L1) for a key project with Southern Railway. This was formally announced on September 22, 2025.

Project Details

The project encompasses the design, supply, erection, testing & commissioning of Traction Sub Stations (Scott-Connected), inclusive of Power Quality Compensating Equipment with Associated Switching Posts (SP/SSP) for 2×25 kV AT Feeding System and SCADA & Automatic Fault Locator (AFL). This is for the Jolarpettai Jn. – Salem Jn. (JTJ-SA) Section of Salem Division of Southern Railway, in connection with Mission 3000MT Loading Target.

Project Cost & Timeline

The total cost of work is Rs 145,34,66,865.48/-.

The project is expected to be completed within 540 days.

Source: BSE

KFin Technologies has issued a clarification regarding a news item suggesting that General Atlantic plans to sell 10-15% of its stake. The company stated that the news is based on rumor and speculation and is inaccurate. KFin Technologies also confirmed that General Atlantic has not indicated any intention to sell its stake. The company’s shares decreased by 5.79% on September 22, 2025.

News Item Clarification

KFin Technologies has addressed a recent news item concerning a potential stake sale by General Atlantic. The company has firmly stated that the news is based on rumor and speculation.

No Intent to Sell Stake

KFin Technologies confirms that General Atlantic, categorized as a Promoter and Promoter Group, has not indicated any intention to sell their stake in the company. The company is unaware of any ongoing negotiations related to this matter. This statement aims to address concerns arising from recent market activity, where share prices decreased by 5.79% on September 22, 2025, moving from Rs. 1149.40 to Rs. 1082.85.

Regulatory Matters

KFin Technologies declares that there are no significant regulatory or legal proceedings against the company.

Source: BSE

Petronet LNG has appointed Roopesh Kumar Tiwari as the new Executive Director (HR), effective September 22, 2025. Tiwari, with over 26 years of experience, will be one level below the Board of Directors. His expertise includes talent management, industrial relations, and HR strategy. He previously worked with Dalmia Bharat Limited.

Executive Leadership Change

Roopesh Kumar Tiwari has joined Petronet LNG as Executive Director (HR) effective September 22, 2025. This appointment places him one level below the Board of Directors, enhancing the company’s leadership team.

About Roopesh Kumar Tiwari

Mr. Tiwari brings a wealth of experience with him, spanning over 26 years across various organizations. His background includes roles at Penna Cement, Kesoram Industries, Dr. Reddy’s Laboratories, and Food Corporation of India Ltd. His expertise covers key areas such as:

• Recruitment
• Employee Engagement
• Performance Management
• Workforce Development

Expertise and Focus Areas

Mr. Tiwari is a certified performance coach and a published author. His specializations include talent management, industrial relations, and organizational development. He also has experience in managing large-scale labour relations and regulatory compliance. His HR strategy will be a key focus for Petronet LNG.

Previous Experience

Before joining Petronet LNG, Mr. Tiwari was associated with Dalmia Bharat Limited.

Source: BSE

IRCTC has announced the appointment of Manoj Kumar Sharma as Director of Catering Services, effective September 22, 2025. This follows previous announcements regarding his initial assumption of the role. Sharma is confirmed to not be debarred from holding the position, and he has no Director/KMP affiliations within the company. His brief profile details his extensive experience in the railway sector.

Director Appointment

Manoj Kumar Sharma has officially assumed the role of Director of Catering Services at IRCTC, effective September 22, 2025. The appointment follows Railway Board’s approval as conveyed in letter No. 2024/E(O)II/40/15 dated September 19, 2025.

Confirmation of Eligibility

IRCTC confirms that Manoj Kumar Sharma is not debarred from holding the office of director, complying with SEBI guidelines. This confirmation is based on internal verification and declarations made by Sharma.

Related Party Disclosure

It is further confirmed that Manoj Kumar Sharma has no existing relationships with any Director/KMP within IRCTC, and he does not hold any shares in the company.

Manoj Kumar Sharma’s Background

Manoj Kumar Sharma, an Indian Railway Traffic Service (IRTS) officer from the 1995 batch, has been with IRCTC since March 12, 2024, initially as Group General Manager/North Zone. With 28 years in the railway sector, he has a background in marketing, business development, operations, transportation, and other critical areas. He has experience working across multiple zones, including Northern, Northeast Frontier, North Eastern, and South East Central Railway.

IRCTC Board of Directors

The current Board of Directors comprises:

• Sanjay Kumar Jain – Chairman & Managing Director
• Sudhir Kumar – Director (Finance) (Additional Charge)
• Rahul Himalian – Director (Tourism & Marketing)
• Manoj Kumar Sharma – Director (Catering Services)
• Shivendra Shukla – Government Nominee Director
• Manoj Kumar Gangeya – Government Nominee Director
• Devendra Pal Bharti – Independent Director
• Sanjay Gaur – Independent Director
• Namgyal Wangchuk – Independent Director

Source: BSE

Kajaria Ceramics announces the resignation of Rajender Mohan Malla from his position as Independent Director, effective from the close of business hours on September 22, 2025. The resignation is attributed to other commitments and personal reasons. Consequently, Mr. Malla will also step down as Chairman of the Nomination and Remuneration Committee and a member of the Audit Committee.

Independent Director Departure

Rajender Mohan Malla (DIN: 00136657) has resigned from his position as Independent Director of Kajaria Ceramics, effective September 22, 2025. The company disclosed that the resignation stems from other commitments and personal considerations.

Committee Roles Relinquished

With his resignation, Mr. Malla will no longer serve as the Chairman of the Nomination and Remuneration Committee. He will also cease to be a member of the Audit Committee of Kajaria Ceramics.

Confirmation of Reasons

Kajaria Ceramics confirmed that Mr. Malla stated there are no undisclosed reasons behind his resignation beyond the cited commitments and personal factors. The company has provided the resignation letter as an attachment to the disclosure.

Source: BSE

Union Bank is scheduled to conduct an Investors/Analysts meet with Millennium Capital Management (Singapore) Pte Limited on September 26, 2025. The meeting will be conducted on a one-to-one virtual basis. The discussion during the meeting will refer to publicly available documents.

Investor Engagement

Union Bank will be meeting with investors and analysts on September 26, 2025.

Meeting Details

The meeting will be conducted with Millennium Capital Management (Singapore) Pte Limited.

Format and Accessibility

The meeting will be held on a one-to-one and virtual basis. The bank will be referencing publicly accessible documents during the discussions.

Important Note

No unpublished price-sensitive information will be shared during the meeting.

Source: BSE

Dr. Reddy’s Laboratories has received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) for its proposed biosimilar of Prolia® and Xgeva® (denosumab). The application, AVT03, aims to address osteoporosis and bone complications. This opinion will be reviewed by the European Commission for marketing authorization in the European Economic Area. Commercialization rights are exclusive for the U.S. and semi-exclusive for Europe and the UK.

European Regulatory Milestone

Dr. Reddy’s Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending marketing authorization for AVT03 (denosumab), a biosimilar of Prolia® and Xgeva®. This announcement was made on September 22, 2025.

AVT03: Proposed Biosimilar

AVT03 is a proposed biosimilar of denosumab, referencing Prolia® and Xgeva®. Prolia® is used to treat osteoporosis in women who have gone through menopause and men at increased risk of fractures. Xgeva® prevents bone complications in adults with advanced cancer involving bone and treats adults and skeletally mature adolescents with giant cell tumor of bone.

Commercialization Strategy

Dr. Reddy’s and Alvotech have a license and supply agreement for AVT03. Alvotech will develop and manufacture AVT03, while Dr. Reddy’s will handle registration and commercialization in applicable markets, including the U.S. and Europe. Dr. Reddy’s has exclusive commercialization rights for the U.S. and semi-exclusive rights for Europe and the UK.

Future Availability

Upon approval, Dr. Reddy’s intends to offer the biosimilar under the tradenames Acvybra® (denosumab) 60 mg/mL solution for injection in a pre-filled syringe and Xbonzy® (denosumab) 70 mg/mL solution for injection in a vial.

Source: BSE